AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. UNH
  4. [Form 4] UNITEDHEALTH GROUP INCORPORATED (Delaware) Insider Trading Activity

[Form 4] UNITEDHEALTH GROUP INCORPORATED (Delaware) Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

UnitedHealth Group Inc. (UNH) filed a Form 4 on 26-Jun-2025 detailing a minor insider transaction by Timothy J. Noel, Chief Executive Officer of UnitedHealthcare (a principal subsidiary).

On 24-Jun-2025, Noel acquired 47.823 shares of UNH common stock at $0.00 per share. The acquisition represents dividend-equivalent units automatically credited on outstanding restricted stock units (RSUs); these units carry the same vesting schedule as the underlying RSUs and will be forfeited if the RSUs do not vest. Following the credit, Noel鈥檚 direct beneficial ownership increased to 9,243.999 shares.

No open-market purchases, option exercises, or cash transactions occurred, and there was no use of a Rule 10b5-1 trading plan. The filing is procedural in nature, recording routine dividend accruals rather than an active investment decision by the insider.

UnitedHealth Group Inc. (UNH) ha presentato un Modulo 4 il 26 giugno 2025, riportando una piccola operazione interna effettuata da Timothy J. Noel, Amministratore Delegato di UnitedHealthcare (una controllata principale).

Il 24 giugno 2025, Noel ha acquisito 47.823 azioni ordinarie UNH a 0,00 $ per azione. L'acquisizione rappresenta unit脿 equivalenti a dividendi automaticamente accreditate su unit脿 azionarie vincolate (RSU) in essere; queste unit脿 seguono lo stesso piano di maturazione delle RSU sottostanti e saranno perse se le RSU non maturano. Dopo l'accredito, la propriet脿 diretta effettiva di Noel 猫 aumentata a 9.243,999 azioni.

Non si sono verificati acquisti sul mercato aperto, esercizi di opzioni o transazioni in contanti, n茅 猫 stato utilizzato un piano di trading secondo la Regola 10b5-1. La comunicazione ha carattere procedurale, registrando accantonamenti di dividendi di routine piuttosto che una decisione attiva di investimento da parte dell'insider.

UnitedHealth Group Inc. (UNH) present贸 un Formulario 4 el 26 de junio de 2025 detallando una peque帽a transacci贸n interna realizada por Timothy J. Noel, Director Ejecutivo de UnitedHealthcare (una subsidiaria principal).

El 24 de junio de 2025, Noel adquiri贸 47.823 acciones ordinarias de UNH a $0.00 por acci贸n. La adquisici贸n representa unidades equivalentes a dividendos acreditadas autom谩ticamente sobre unidades restringidas de acciones (RSU) en circulaci贸n; estas unidades tienen el mismo calendario de adquisici贸n que las RSU subyacentes y se perder谩n si las RSU no se consolidan. Tras el abono, la propiedad directa beneficiaria de Noel aument贸 a 9,243.999 acciones.

No hubo compras en el mercado abierto, ejercicios de opciones ni transacciones en efectivo, y no se utiliz贸 un plan de negociaci贸n seg煤n la Regla 10b5-1. La presentaci贸n es de car谩cter procedimental, registrando acumulaciones rutinarias de dividendos en lugar de una decisi贸n activa de inversi贸n por parte del insider.

UnitedHealth Group Inc.(UNH)電� 2025雲� 6鞗� 26鞚�, UnitedHealthcare(欤检殧 鞛愴殞靷�)鞚� 斓滉碃瓴届榿鞛� Timothy J. Noel鞚� 靻岅窚氇� 雮措秬鞛� 瓯半灅毳� 靸侅劯頌� 旮办灛頃� Form 4毳� 鞝滌稖頄堨姷雼堧嫟.

2025雲� 6鞗� 24鞚�, Noel鞚赌 UNH 氤错喌欤� 47,823欤茧ゼ 欤茧嫻 0.00雼煬鞐� 旆摑頄堨姷雼堧嫟. 鞚� 旆摑鞚赌 氙戈舶 鞝滍暅 欤检嫕 雼渼(RSU)鞐� 鞛愲彊鞙茧 鞝侂霅� 氚半嫻旮� 靸侂嫻 雼渼搿�, 鞚� 雼渼霌れ澏� 旮办磮 RSU鞕� 霃欖澕頃� 氩犾姢韺� 鞚检爼鞚� 鞝侅毄霅橂┌ RSU臧� 氩犾姢韸鸽悩歆� 鞎婌溂氅� 氇办垬霅╇媹雼�. 鞝侂 頉� Noel鞚� 歆侅爲 靻岇湢 歆�攵�鞚赌 9,243.999欤�搿� 歃濌皜頄堨姷雼堧嫟.

鞁滌灔 雮� 臧滊硠 毵れ垬, 鞓奠厴 頄夓偓 霕愲姅 順勱笀 瓯半灅電� 鞐嗢棃鞙茧┌, Rule 10b5-1 瓯半灅 瓿勴殟霃� 靷毄頃橃 鞎婌晿鞀惦媹雼�. 鞚措矆 鞝滌稖鞚赌 雮措秬鞛愳潣 鞝侁饭鞝侅澑 韴瀽 瓴办爼鞚� 鞎勲媽 鞚检儊鞝侅澑 氚半嫻 鞝侂鞚� 旮半頃橂姅 鞝堨皑鞝侅澑 靹标博鞛呺媹雼�.

UnitedHealth Group Inc. (UNH) a d茅pos茅 un formulaire 4 le 26 juin 2025 d茅taillant une transaction interne mineure r茅alis茅e par Timothy J. Noel, directeur g茅n茅ral de UnitedHealthcare (une filiale principale).

Le 24 juin 2025, Noel a acquis 47 823 actions ordinaires UNH 脿 0,00 $ par action. Cette acquisition correspond 脿 des unit茅s 茅quivalentes de dividendes automatiquement cr茅dit茅es sur des unit茅s d鈥檃ctions restreintes (RSU) en circulation ; ces unit茅s suivent le m锚me calendrier d鈥檃cquisition que les RSU sous-jacentes et seront perdues si les RSU ne sont pas acquises. Apr猫s ce cr茅dit, la possession directe b茅n茅ficiaire de Noel est pass茅e 脿 9 243,999 actions.

Aucun achat sur le march茅 ouvert, exercice d鈥檕ptions ou transaction en esp猫ces n鈥檃 eu lieu, et aucun plan de n茅gociation conforme 脿 la r猫gle 10b5-1 n鈥檃 茅t茅 utilis茅. Le d茅p么t est de nature proc茅durale, enregistrant des accumulations de dividendes de routine plut么t qu鈥檜ne d茅cision d鈥檌nvestissement active de l鈥檌niti茅.

UnitedHealth Group Inc. (UNH) reichte am 26. Juni 2025 ein Formular 4 ein, das eine kleinere Insider-Transaktion von Timothy J. Noel, CEO von UnitedHealthcare (einer Haupttochtergesellschaft), detailliert beschreibt.

Am 24. Juni 2025 erwarb Noel 47.823 Aktien der UNH-Stammaktien zu 0,00 $ pro Aktie. Der Erwerb stellt dividenden盲quivalente Einheiten dar, die automatisch auf ausstehenden Restricted Stock Units (RSUs) gutgeschrieben werden; diese Einheiten unterliegen dem gleichen Vesting-Zeitplan wie die zugrunde liegenden RSUs und verfallen, wenn die RSUs nicht vesten. Nach der Gutschrift erh枚hte sich Noels direktes wirtschaftliches Eigentum auf 9.243,999 Aktien.

Es fanden keine K盲ufe am offenen Markt, keine Aus眉bung von Optionen oder Bartransaktionen statt, und es wurde kein Rule 10b5-1 Handelsplan verwendet. Die Meldung ist prozeduraler Natur und erfasst routinem盲脽ige Dividendengutschriften, nicht jedoch eine aktive Investitionsentscheidung des Insiders.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine dividend-equivalent credit; immaterial to UNH valuation or insider sentiment.

The Form 4 shows a non-cash addition of 47.823 shares tied to RSU dividend equivalents. Such credits are common and signal neither bullish nor bearish intent. Noel鈥檚 total holdings rise marginally to ~9.2k shares, a tiny fraction of UNH鈥檚 928 m fully diluted shares outstanding. Because the units remain subject to RSU vesting, there is no immediate liquidity impact. From a market perspective, the transaction is neutral and provides no incremental insight into future operating performance.

TL;DR: Administrative insider filing; reflects standard equity compensation mechanics, not governance concern.

This filing complies with Section 16 reporting rules, evidencing transparency around equity-based pay. The absence of a Rule 10b5-1 designation confirms the credit occurred automatically under the RSU plan. No red flags emerge regarding timing, volume, or pricing. The event neither alters insider control dynamics nor suggests governance risk. Overall, the impact on shareholders鈥� oversight considerations is minimal.

UnitedHealth Group Inc. (UNH) ha presentato un Modulo 4 il 26 giugno 2025, riportando una piccola operazione interna effettuata da Timothy J. Noel, Amministratore Delegato di UnitedHealthcare (una controllata principale).

Il 24 giugno 2025, Noel ha acquisito 47.823 azioni ordinarie UNH a 0,00 $ per azione. L'acquisizione rappresenta unit脿 equivalenti a dividendi automaticamente accreditate su unit脿 azionarie vincolate (RSU) in essere; queste unit脿 seguono lo stesso piano di maturazione delle RSU sottostanti e saranno perse se le RSU non maturano. Dopo l'accredito, la propriet脿 diretta effettiva di Noel 猫 aumentata a 9.243,999 azioni.

Non si sono verificati acquisti sul mercato aperto, esercizi di opzioni o transazioni in contanti, n茅 猫 stato utilizzato un piano di trading secondo la Regola 10b5-1. La comunicazione ha carattere procedurale, registrando accantonamenti di dividendi di routine piuttosto che una decisione attiva di investimento da parte dell'insider.

UnitedHealth Group Inc. (UNH) present贸 un Formulario 4 el 26 de junio de 2025 detallando una peque帽a transacci贸n interna realizada por Timothy J. Noel, Director Ejecutivo de UnitedHealthcare (una subsidiaria principal).

El 24 de junio de 2025, Noel adquiri贸 47.823 acciones ordinarias de UNH a $0.00 por acci贸n. La adquisici贸n representa unidades equivalentes a dividendos acreditadas autom谩ticamente sobre unidades restringidas de acciones (RSU) en circulaci贸n; estas unidades tienen el mismo calendario de adquisici贸n que las RSU subyacentes y se perder谩n si las RSU no se consolidan. Tras el abono, la propiedad directa beneficiaria de Noel aument贸 a 9,243.999 acciones.

No hubo compras en el mercado abierto, ejercicios de opciones ni transacciones en efectivo, y no se utiliz贸 un plan de negociaci贸n seg煤n la Regla 10b5-1. La presentaci贸n es de car谩cter procedimental, registrando acumulaciones rutinarias de dividendos en lugar de una decisi贸n activa de inversi贸n por parte del insider.

UnitedHealth Group Inc.(UNH)電� 2025雲� 6鞗� 26鞚�, UnitedHealthcare(欤检殧 鞛愴殞靷�)鞚� 斓滉碃瓴届榿鞛� Timothy J. Noel鞚� 靻岅窚氇� 雮措秬鞛� 瓯半灅毳� 靸侅劯頌� 旮办灛頃� Form 4毳� 鞝滌稖頄堨姷雼堧嫟.

2025雲� 6鞗� 24鞚�, Noel鞚赌 UNH 氤错喌欤� 47,823欤茧ゼ 欤茧嫻 0.00雼煬鞐� 旆摑頄堨姷雼堧嫟. 鞚� 旆摑鞚赌 氙戈舶 鞝滍暅 欤检嫕 雼渼(RSU)鞐� 鞛愲彊鞙茧 鞝侂霅� 氚半嫻旮� 靸侂嫻 雼渼搿�, 鞚� 雼渼霌れ澏� 旮办磮 RSU鞕� 霃欖澕頃� 氩犾姢韺� 鞚检爼鞚� 鞝侅毄霅橂┌ RSU臧� 氩犾姢韸鸽悩歆� 鞎婌溂氅� 氇办垬霅╇媹雼�. 鞝侂 頉� Noel鞚� 歆侅爲 靻岇湢 歆�攵�鞚赌 9,243.999欤�搿� 歃濌皜頄堨姷雼堧嫟.

鞁滌灔 雮� 臧滊硠 毵れ垬, 鞓奠厴 頄夓偓 霕愲姅 順勱笀 瓯半灅電� 鞐嗢棃鞙茧┌, Rule 10b5-1 瓯半灅 瓿勴殟霃� 靷毄頃橃 鞎婌晿鞀惦媹雼�. 鞚措矆 鞝滌稖鞚赌 雮措秬鞛愳潣 鞝侁饭鞝侅澑 韴瀽 瓴办爼鞚� 鞎勲媽 鞚检儊鞝侅澑 氚半嫻 鞝侂鞚� 旮半頃橂姅 鞝堨皑鞝侅澑 靹标博鞛呺媹雼�.

UnitedHealth Group Inc. (UNH) a d茅pos茅 un formulaire 4 le 26 juin 2025 d茅taillant une transaction interne mineure r茅alis茅e par Timothy J. Noel, directeur g茅n茅ral de UnitedHealthcare (une filiale principale).

Le 24 juin 2025, Noel a acquis 47 823 actions ordinaires UNH 脿 0,00 $ par action. Cette acquisition correspond 脿 des unit茅s 茅quivalentes de dividendes automatiquement cr茅dit茅es sur des unit茅s d鈥檃ctions restreintes (RSU) en circulation ; ces unit茅s suivent le m锚me calendrier d鈥檃cquisition que les RSU sous-jacentes et seront perdues si les RSU ne sont pas acquises. Apr猫s ce cr茅dit, la possession directe b茅n茅ficiaire de Noel est pass茅e 脿 9 243,999 actions.

Aucun achat sur le march茅 ouvert, exercice d鈥檕ptions ou transaction en esp猫ces n鈥檃 eu lieu, et aucun plan de n茅gociation conforme 脿 la r猫gle 10b5-1 n鈥檃 茅t茅 utilis茅. Le d茅p么t est de nature proc茅durale, enregistrant des accumulations de dividendes de routine plut么t qu鈥檜ne d茅cision d鈥檌nvestissement active de l鈥檌niti茅.

UnitedHealth Group Inc. (UNH) reichte am 26. Juni 2025 ein Formular 4 ein, das eine kleinere Insider-Transaktion von Timothy J. Noel, CEO von UnitedHealthcare (einer Haupttochtergesellschaft), detailliert beschreibt.

Am 24. Juni 2025 erwarb Noel 47.823 Aktien der UNH-Stammaktien zu 0,00 $ pro Aktie. Der Erwerb stellt dividenden盲quivalente Einheiten dar, die automatisch auf ausstehenden Restricted Stock Units (RSUs) gutgeschrieben werden; diese Einheiten unterliegen dem gleichen Vesting-Zeitplan wie die zugrunde liegenden RSUs und verfallen, wenn die RSUs nicht vesten. Nach der Gutschrift erh枚hte sich Noels direktes wirtschaftliches Eigentum auf 9.243,999 Aktien.

Es fanden keine K盲ufe am offenen Markt, keine Aus眉bung von Optionen oder Bartransaktionen statt, und es wurde kein Rule 10b5-1 Handelsplan verwendet. Die Meldung ist prozeduraler Natur und erfasst routinem盲脽ige Dividendengutschriften, nicht jedoch eine aktive Investitionsentscheidung des Insiders.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Noel Timothy John
(Last) (First) (Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE
(Street)
EDEN PRAIRIE MN 55344
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer, UHC
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/24/2025 A 47.823(1) A $0 9,243.999 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for Timothy J. Noel 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did Timothy J. Noel acquire in the latest UNH Form 4 filing?

47.823 shares of UNH common stock, credited as dividend equivalents on existing RSUs.

Was cash paid for the 47.823 UNH shares reported on 24-Jun-2025?

No. The shares were credited at $0.00 as part of RSU dividend equivalents.

How many UNH shares does Noel own after the transaction?

He now directly holds 9,243.999 shares.

Does the filing indicate use of a Rule 10b5-1 trading plan?

No. The corresponding checkbox was left blank.

Are the credited dividend equivalents immediately vested?

No. They carry the same vesting terms as the underlying RSUs and could be forfeited.
Stock UNH logo
Unitedhealth Gp

NYSE:UNH

UNH Rankings

#40 Ranked by Market Cap
#1272 Ranked by Dividends

UNH Latest News

UNH Latest SEC Filings

UNH Stock Data

246.17B
904.48M
0.27%
90.58%
1.4%
Healthcare Plans
Hospital & Medical Service Plans
United States
EDEN PRAIRIE